David Baxley Spetzler
President at Caris Life Sciences, Inc. (CAI)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys+$2K
Total bought / sold$10K / $14.8M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 4SEC | CAICaris Life Sciences, Inc. | Sell | 393,1001,136,983 held (−26%) | $24.76 | $9.7M | +20.0% |
| Sep 4SEC | CAICaris Life Sciences, Inc. | Sell | 84,9001,052,083 held (−7%) | $25.32 | $2.1M | +17.3% |
| Sep 4SEC | CAICaris Life Sciences, Inc. | Sell | 119,2121,182,871 held (−9%) | $24.76 | $3.0M | +20.0% |
| Nov 10SEC | CAICaris Life Sciences, Inc. | Buy | 400460,777 held (+0%) | $23.85 | $10K | +24.5% |
- Sell
President David Baxley Spetzler sold $9.7M of CAI at $24.76 — cuts the stake by 26%.
- Buy
President David Baxley Spetzler bought $10K of CAI at $23.85 — first open-market purchase in our records.